Allecra Therapeutics
Novel antibiotics to combat drug-resistant bacterial infections
Total raised
€37M
€37,000,000
Funding rounds
2
Investors
4
distinct backers
Active since
2015-03
latest 2016-05
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood20
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ €30M+ raised
- ▲ 13y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-06-01 | Series B | €22M | Delos Capital,Edmond de Rothschild Venture Capital,EMBL Ventures,Forbion Capital Partners | View deal → |
| 2015-04-01 | Series A | €15M | Edmond de Rothschild Venture Capital,EMBL Ventures | View deal → |
Related news
Similar companies
same sector or country- Delivery Hero€7.3BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Celonis€2.1BGermany · Software